Abstract: The present invention relates to the use of matrices in cell recruitment and the to modified matrices comprising homing factors for in vivo recellularisation of implantable medical devices such as cardiac valves and vascular grafts.
Type:
Application
Filed:
May 8, 2007
Publication date:
November 15, 2007
Applicants:
K.U. LEUVEN RESEARCH & DEVELOPMENT, ALPHA-GEN N.V.